Stockscreener 앱 받기
6.505
1.96%
-0.125
시간 외 거래:
6.50
-0.005
-0.08%
전일 마감가:
$6.63
열려 있는:
$6.66
하루 거래량:
152.01K
Relative Volume:
0.98
시가총액:
$243.53M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
130.10
EPS:
0.05
순현금흐름:
$-8.79M
1주 성능:
-6.88%
1개월 성능:
-7.28%
6개월 성능:
+13.74%
1년 성능:
+44.93%
1일 변동 폭
$6.44
$6.67
1주일 범위
$6.44
$7.115
52주 변동 폭
$4.33
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.505 | 248.40M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
141.09 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.99 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | 개시 | William Blair | Outperform |
| 2024-09-05 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Will Lifecore Biomedical Inc. bounce back from current supportQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
Chart overlay techniques for tracking Lifecore Biomedical Inc.2025 Geopolitical Influence & Community Verified Trade Signals - newser.com
Is it time to cut losses on Lifecore Biomedical Inc.Watch List & Stepwise Entry and Exit Trade Signals - newser.com
How Lifecore Biomedical Inc. (LDE) stock compares with market leadersTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Analyzing net buyer seller activity in Lifecore Biomedical Inc.2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
With 45% stake, Lifecore Biomedical, Inc. (NASDAQ:LFCR) seems to have captured hedge funds investors' interest - Yahoo Finance
Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR) - Seeking Alpha
CEO Insights: Industry Trends Driving Strong Tailwinds for U.S.-based CDMOs - Contract Pharma
Using fundamentals and technicals on Lifecore Biomedical Inc.Swing Trade & Weekly Watchlist for Hot Stocks - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockMarket Growth Report & Reliable Price Breakout Alerts - newser.com
Real time alert setup for Lifecore Biomedical Inc. performanceQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-05 05:34:33 - newser.com
Lifecore granted Sector Weight rating at KeyBanc on growth trajectory - MSN
Can volume confirm reversal in Lifecore Biomedical Inc.Market Trend Report & AI Driven Price Forecasts - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index funds2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Quantitative breakdown of Lifecore Biomedical Inc. recent moveOil Prices & Real-Time Stock Entry Alerts - newser.com
LIFECORE SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
What drives Lifecore Biomedical Inc stock priceStock Buy Signals & Big Returns, Small Investment – Learn How - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
What analysts say about Lifecore Biomedical Inc LDE stockStraddle and Strangle Trades & Free Stock Education Platform for New Investors - earlytimes.in
What analysts say about Lifecore Biomedical Inc stockMarket Correction Analysis & High Profit Market Growth - earlytimes.in
Is Lifecore Biomedical Inc a good long term investmentTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
Will Lifecore Biomedical Inc. (LDE) stock deliver compounding returnsMarket Rally & Weekly Market Pulse Updates - newser.com
What drives Lifecore Biomedical Inc LDE stock priceEx-Dividend Date Alerts & Small Budget Trading Plans - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Published on: 2025-09-27 16:31:16 - newser.com
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lifecore Biomedical Inc 주식 (LFCR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
1.54%
1.16%
자본화:
|
볼륨(24시간):